WallStSmart

Mizuho Financial Group Inc. (MFG)vsTexas Capital Bancshares Inc (TCBIO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Mizuho Financial Group Inc. generates 334502% more annual revenue ($4.02T vs $1.20B). TCBIO leads profitability with a 27.5% profit margin vs 26.1%. TCBIO trades at a lower P/E of 5.5x. MFG earns a higher WallStSmart Score of 74/100 (B).

MFG

Strong Buy

74

out of 100

Grade: B

Growth: 8.0Profit: 7.5Value: 10.0Quality: 5.0

TCBIO

Buy

52

out of 100

Grade: C-

Growth: 8.7Profit: 7.5Value: 8.3Quality: 5.5
Piotroski: 7/9Altman Z: -0.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MFGUndervalued (+42.4%)

Margin of Safety

+42.4%

Fair Value

$17.51

Current Price

$7.81

$9.70 discount

UndervaluedFair: $17.51Overvalued
TCBIOUndervalued (+88.3%)

Margin of Safety

+88.3%

Fair Value

$185.28

Current Price

$22.07

$163.21 discount

UndervaluedFair: $185.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MFG6 strengths · Avg: 9.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
36.3%10/10

Strong operational efficiency at 36.3%

Market CapQuality
$92.84B9/10

Large-cap with strong market position

Profit MarginProfitability
26.1%9/10

Keeps 26 of every $100 in revenue as profit

PEG RatioValuation
0.868/10

Growing faster than its price suggests

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

TCBIO6 strengths · Avg: 9.3/10
P/E RatioValuation
5.5x10/10

Attractively priced relative to earnings

Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
42.5%10/10

Strong operational efficiency at 42.5%

Profit MarginProfitability
27.5%9/10

Keeps 28 of every $100 in revenue as profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
19.1%8/10

19.1% revenue growth

Areas to Watch

MFG0 concerns · Avg: 0/10

No major concerns identified

TCBIO1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
-0.542/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MFG

The strongest argument for MFG centers on Price/Book, Operating Margin, Market Cap. Profitability is solid with margins at 26.1% and operating margin at 36.3%. PEG of 0.86 suggests the stock is reasonably priced for its growth.

Bull Case : TCBIO

The strongest argument for TCBIO centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 27.5% and operating margin at 42.5%. Revenue growth of 19.1% demonstrates continued momentum.

Bear Case : MFG

No major red flags identified for MFG, but monitor valuation.

Bear Case : TCBIO

The primary concerns for TCBIO are Altman Z-Score.

Key Dynamics to Monitor

MFG profiles as a mature stock while TCBIO is a growth play — different risk/reward profiles.

TCBIO carries more volatility with a beta of 0.69 — expect wider price swings.

TCBIO is growing revenue faster at 19.1% — sustainability is the question.

Monitor BANKS - REGIONAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MFG scores higher overall (74/100 vs 52/100), backed by strong 26.1% margins. TCBIO offers better value entry with a 88.3% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Mizuho Financial Group Inc.

FINANCIAL SERVICES · BANKS - REGIONAL · USA

Mizuho Financial Group, Inc. engages in banking, trusts, securities and other businesses related to financial services in Japan, America, Europe, Asia / Oceania and internationally. The company is headquartered in Tokyo, Japan.

Texas Capital Bancshares Inc

FINANCIAL SERVICES · BANKS - REGIONAL · USA

Texas Capital Bancshares Inc (TCBIO), based in Dallas, Texas, is a prominent banking institution that delivers a wide array of financial solutions tailored to both commercial and private clients. The company specializes in business loans, treasury management, and personal banking services, underpinned by a commitment to customer relationship excellence and regional market knowledge. With a focus on disciplined risk management and strategic growth initiatives, TCBIO is well-positioned to navigate the competitive landscape and capitalize on emerging opportunities, thereby ensuring long-term value creation for its shareholders.

Want to dig deeper into these stocks?